## Note
nid: 1518024093214
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Pathoma_Chapter_3_(Neoplasia), #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::09_Tumor_Suppressor_Genes, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::09_Tumor_Suppressor_Genes::PTEN, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pathoma::03_Neoplasia::02_Carcinogenesis::2_Oncogenes, #AK_Step1_v11::#Pathoma::03_Neoplasia_Alt_Tagging::BlueGalaxies::02_Carcinogenesis::2_Oncogenes, #AK_Step1_v11::#Physeo::11_Pathology::07_General_Pathology::09_Carcinogenesis, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^FA_Updates::FA2018
markdown: false

### Text
Mutations in PTEN lead to overactivity of {{c1::mTOR}} proto-oncogene

### Extra
- PTEN is tumor suppressor that works by dephosphorylating
PIP<sub>3</sub> to PIP<sub>2</sub> (PIP<sub>3</sub> normally leads
to activation of mTOR)
<div>
  PI3 Kinase pathway <u>activates</u> mTOR
  <div><img src="paste-151556510973953.jpg"></div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

